Today’s Stock Alert: E I Du Pont De Nemours And Co Stock Price Gaps Up Today; Buyers Are Thriving

Today's Stock Alert: E I Du Pont De Nemours And Co Stock Price Gaps Up Today; Buyers Are Thriving

The stock of E I Du Pont De Nemours And Co (NYSE:DD) gapped up by $0.07 today and has $112.61 target or 66.00% above today’s $67.84 share price. The 7 months technical chart setup indicates low risk for the $59.85 billion company. The gap was reported on Oct, 4 by If the $112.61 price target is reached, the company will be worth $39.50 billion more.
Gaps up are useful for using as a support level and to some extent as a tradeable event. If investors already hold the stock and experience a price gap up, then its usually a good idea to hold the stock for a stronger up move. Back-tests of these patterns indicate that two-thirds of the times the stock performance improves after the gap. The area gaps close 89% of the time, the breakaway gaps, 2%, the continuation gaps 4% and the exhaustion gaps 61%. The stock increased 1.30% or $0.87 during the last trading session, hitting $67.84. About 2.40M shares traded hands. E I Du Pont De Nemours And Co (NYSE:DD) has risen 7.79% since March 1, 2016 and is uptrending. It has underperformed by 4.43% the S&P500.

Analysts await E I Du Pont De Nemours And Co (NYSE:DD) to report earnings on October, 25 before the open. They expect $0.20 EPS, up 53.85% or $0.07 from last year’s $0.13 per share. DD’s profit will be $176.44 million for 84.80 P/E if the $0.20 EPS becomes a reality. After $1.24 actual EPS reported by E I Du Pont De Nemours And Co for the previous quarter, Wall Street now forecasts -83.87% negative EPS growth.

E I Du Pont De Nemours And Co (NYSE:DD) Ratings Coverage

Out of 16 analysts covering Du Pont (NYSE:DD), 6 rate it a “Buy”, 3 “Sell”, while 7 “Hold”. This means 38% are positive. Du Pont has been the topic of 39 analyst reports since July 30, 2015 according to StockzIntelligence Inc. Wells Fargo upgraded the shares of DD in a report on Monday, December 14 to “Outperform” rating. The stock has “Overweight” rating given by JP Morgan on Friday, August 14. On Thursday, December 10 the stock rating was maintained by Deutsche Bank with “Buy”. On Friday, February 26 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The stock of E I Du Pont De Nemours And Co (NYSE:DD) earned “Hold” rating by Jefferies on Monday, December 14. The rating was upgraded by Bernstein on Friday, January 8 to “Outperform”. The firm earned “Sector Perform” rating on Friday, December 4 by RBC Capital Markets. The company was maintained on Tuesday, October 6 by Deutsche Bank. Citigroup upgraded it to “Buy” rating and $63 target price in Tuesday, September 22 report. The stock of E I Du Pont De Nemours And Co (NYSE:DD) has “Buy” rating given on Tuesday, August 25 by Vetr.

According to Zacks Investment Research, “E.I. DuPont de Nemours is involved in science and technology in a range of disciplines including high-performance materials, specialty chemicals, pharmaceuticals and biotechnology. The company operates globally through strategic business units. Within the strategic business units, businesses manufacture and sell a wide range of products to many different markets, including the transportation, textile, construction, automotive, agricultural and hybrid seeds, nutrition and health, pharmaceuticals, packaging and electronics markets.”

Insitutional Activity: The institutional sentiment increased to 0.66 in 2016 Q2. Its up 0.04, from 0.62 in 2016Q1. The ratio is positive, as 63 funds sold all E I Du Pont De Nemours And Co shares owned while 474 reduced positions. 67 funds bought stakes while 289 increased positions. They now own 608.14 million shares or 1.55% less from 617.73 million shares in 2016Q1.
Retail Bank Of Nova Scotia has invested 0.01% of its portfolio in E I Du Pont De Nemours And Co (NYSE:DD). Glenview Cap Mgmt Ltd Liability owns 1.82M shares or 0.83% of their US portfolio. Lenox Wealth Advsrs holds 0.02% of its portfolio in E I Du Pont De Nemours And Co (NYSE:DD) for 1,000 shares. Moreover, Denver Invest Advsrs Lc has 0.04% invested in E I Du Pont De Nemours And Co (NYSE:DD) for 13,126 shares. Vanguard Group Inc owns 55.88 million shares or 0.22% of their US portfolio. The Florida-based Sabal Tru Co has invested 0.05% in E I Du Pont De Nemours And Co (NYSE:DD). Vantage Prtnrs Limited Liability Com accumulated 2,644 shares or 0.02% of the stock. Moors And Cabot accumulated 0.63% or 55,229 shares. The New York-based Chesapeake Asset Mgmt Lc has invested 0.17% in E I Du Pont De Nemours And Co (NYSE:DD). Suntrust Banks holds 431,768 shares or 0.17% of its portfolio. The North Carolina-based Franklin Street Advsr Inc Nc has invested 0.18% in E I Du Pont De Nemours And Co (NYSE:DD). The United Kingdom-based Rathbone Brothers Public Ltd Com has invested 0.02% in E I Du Pont De Nemours And Co (NYSE:DD). Geneva Advisors Ltd last reported 46,121 shares in the company. Frontier Inv Management holds 0.08% or 10,165 shares in its portfolio. Cowen accumulated 50,518 shares or 0.22% of the stock.

Insider Transactions: Since August 24, 2016, the stock had 0 insider buys, and 3 insider sales for $8.06 million net activity. $376,993 worth of E I Du Pont De Nemours And Co (NYSE:DD) was sold by Doyle Christopher Marc on Friday, August 26. Cachinero Benito had sold 58,958 shares worth $4.15 million. Shares for $3.54M were sold by Collins James C. Jr. on Wednesday, August 24.

DD Company Profile

E. I. du Pont de Nemours and Company (DuPont), incorporated on October 4, 1915, is a science and technology company. The Firm consists of over 10 businesses aggregated into six divisions, which include Agriculture, Electronics & Communications (E&C), Industrial Biosciences, Nutrition & Health, Performance Materials and Safety & Protection. The Firm is also involved in other businesses, such as pre-commercial programs, nonaligned businesses and pharmaceuticals in other. It conducts research and development (R&D) programs in various fields, including agriculture, biology, chemistry, engineering and materials science.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment